Keros Therapeutics CEO Jasbir Seehra's 2022 pay slips 11% to $6.5M
Keros Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 24, 2023
Keros Therapeutics reported fiscal year 2022 executive compensation information on April 24, 2023.
In 2022, three executives at Keros Therapeutics received on average a compensation package of $4.3M, which is about the same as previous year.
Jasbir Seehra, Chief Executive Officer, received $6.5M in total, which decreased by 11% compared to 2021. 85% of Seehra's compensation, or $5.5M, was in option awards. Seehra also received $61K in bonus, $303K in non-equity incentive plan, $611K in salary, as well as $12K in other compensation.
Christopher Rovaldi, Chief Operating Officer, received a compensation package of $4.2M. 83% of the compensation package, or $3.5M, was in option awards.
Simon Cooper, M.B.B.S, Chief Medical Officer, earned $2.3M in 2022.